chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Did not get 2nd Vaccine as scheduled; rash head to toe/rash on chest/Rash over arms; Very bad itch; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Very bad itch), PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled), RASH (Rash) and RASH (rash head to toe/rash on chest/Rash over arms) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included ADALIMUMAB (HUMIRA AC), LEVOTHYROXINE SODIUM (SYNTHROID), MONTELUKAST, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and METHOTREXATE SODIUM (MTX DURA) for an unknown indication, AVOBENZONE, OCTINOXATE (SUNSCREEN), FOLIC ACID, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and CALCIUM.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRURITUS (Very bad itch) and RASH (Rash). On 29-Mar-2021, the patient experienced RASH (rash head to toe/rash on chest/Rash over arms). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PREDNISONE at an unspecified dose and frequency. On 22-Apr-2021, RASH (rash head to toe/rash on chest/Rash over arms) had not resolved. At the time of the report, PRURITUS (Very bad itch) and PRODUCT DOSE OMISSION ISSUE (Did not get 2nd Vaccine as scheduled) had resolved and RASH (Rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes steroids   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Medical history, concomitant medication and new events were added
Itching and rash began 2/21/21 at injection site. Today (2/25/21) trash now extends from to of L shoulder spiraling toward inside of arm 2 inches above L elbow. Some swelling, hot to touch, itching, no pain.Have put ice on it. Contacted doctor and sent picture. She said it was normal and not to worry.
SEVERE HEADACHE, BODYACHE, AND ARM MUSCLE PAIN.  ARM WHERE SHOT WAS GIVEN WAS VISIBLY SWOLLEN.
I was administering 5 vaccines all together for the patient and his significant other. Three were for him and  2 for her. I had thought I separated each vaccine out separately for the patients, but after administering the second Typhoid vaccine to the patient, I then realized I gave him two of the same vaccine. I told him to stay in for 15 minutes in case he had any adverse events and to call immediately if he does and to call his primary care provider know.
Patient was given a monovalent pfizer vaccine as a booster. Patient should have been given the bivalent pfizer vaccine as a booster. No adverse outcomes. PCP consulted. Patient advised per CDC that repeat dose needed in at least two months.
Large rash appeared over a week after the 1st dose at the injection site. Changes shape, hot, raised, itching, and painful.
Patients arm swelled up near the elbow, away from site of injection. Arm was sore but no sharp pain. Patient went to urgent care and was Prescribed an antibiotic/cephalexin and benadryl as prophylaxis.
Breakthrough Covid case (positive result and symptoms); Breakthrough Covid case (positive result and symptoms); This is a spontaneous report from a contactable consumer (patient herself). A 38-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EW0151), via intramuscular route, administered in right arm on 14Apr2021 (age at vaccination: 38-year-old) as dose 2, single for covid-19 immunization and dose 1 via intramuscular route, administered in right arm on 08Mar2021 (age at vaccination: 38-year-old) (Lot Number: EL3247) as dose 1, single for covid-19 immunization. The patient's medical history included allergy. The patient's concomitant medications were not reported. The vaccine was administered in a pharmacy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or other medications the patient received within 2 weeks of vaccination. On 13Oct2021, the patient experienced breakthrough covid case. On 14Oct2021, the patient sars-cov-2 test (saliva PCR) was positive. The patient was not hospitalized nor received any treatment for the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. The outcome of the event COVID-19 was not recovered.  Follow-up attempts are completed. No further information is expected.
Light-headedness two weeks after second vaccine dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Mar2021 17:00 (Lot number: EL9266) at the age of 66 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, single, Lot no: EP6955, on 13Feb2021 at 05:00 PM administered in the right arm), administration date: 13Feb2021, when the patient was 66 years old, for Covid-19 Immunisation, reaction(s): "Vertigo", "Loud noise amplified". The following information was reported: DIZZINESS (non-serious) with onset 02Apr2021, outcome "unknown", described as "Light-headedness two weeks after second vaccine dose".  Additional information: There was no Covid prior to vaccination, and no Covid was tested after vaccination.  No follow-up attempts are possible. No further information is expected.
Pt having  body aches, diarrhea, fever and back pain for 3 days
2nd dose not yet given; This case was reported by a physician and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: Age at vaccination was not applicable for this report. Physician reported 2nd dose of Shingrix greater than 6 months and 2nd dose not yet given which led to incomplete course of vaccination. The reporter did not consent to follow-up.
Per call from patient's mother, patient received vaccine and while travelling in car on way home suffered what appeared to be a seizure. Patient was taken to hospital and given supportive care.
Shooting pain, Shoulder joint pain, worse when still in AM and across the shoulders in the back pain.
11-year-old patient given COVID-19 vaccine for 12 years and older (0.3 mL) instead of vaccine for 5 to 11-year-old (10mcg/0.2mL).
INJECTION SITE BECAME WARM AND SINK SURROUNDING THE SITE OF INJECTION BECAME PINK.
mom states 8JUL98 vomited x 1;sl fever, lt arm warm, red, swollen, painful;has ROM;by 2PM 8JUL98 no fever, no nausea;5Pm 10JUL98 lt arm markedly less swollen, warm & red & painful;no further c/o vomit or fever;
After the COVID Vaccination around 3am in the morning this writer had a very bad case of Acid Reflux/Heartburn and Insomnia. This writer continues with the adverse reactions as of 5/17/2021. This writer was able to take over the counter acid reflux medications and  Melatonin  6mg . Medications have helped a little.
Onset 7 days after vaccination: Remarkable L deltoid swelling, warmth, itch. No erythema. Skin around full deltoid quite taut.
Started having pain and difficulty urinating last night. Had to get up during the night to go a few times as well. Calling doctor?s office this morning. It is a bit concerning as my brother ended up with a UTI  a few days after his second shot  and was treated with antibiotics
Two weeks after Moderna booster, I became ill. I was exposed to Covid-19 in the work setting that week.  For two days had a fever of 101-99.8, extremely sore throat, vomited twice, mild chills, nausea, mild headache, dizziness, mild drainage down throat, and ear congestion. On day two I did a Covid-19 home lateral flow test, which came back inconclusive. On day three was tested for strep, and both the rapid test and culture came back negative. I was told by my CNP to assume I had Covid-19 and to treat it as such. For an additional six days experienced sore throat, congestion, ear congestion, mild sinus pressure, hoarse to no voice, gooey eyes, and mild cough. On day five my left eardrum ruptured due to congestion. Consulted my CNP, and she diagnosed a middle ear infection with ruptured ear drum, and put me on a 10 day course of amoxicillin as a preventive measure for infection. Ear congestion continued for an additional five days as it healed. Overall, treated symptoms with Advil as needed, rest, and steam for congestion. I missed a week of work due to discomfort and precautionary quarantine.
right deltoid swelling with knot. Advised parent to given Motrin as needed for pain/swelling.
On 1/20 21  2nd injection around 10:00am  sore left arm. around 2:45pm  right eye slightly  swollen - slight headache. On 1/21 3:45am right eye swollen, (but not swollen shut) a little ache -slight headache.
Stomach upset, feverish (but no temperature), muscle aches; took 1 Motrin at 6 PM; felt better 8 PM.
Severe vertigo; Nausea; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 17:15 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. Other vaccine received within 4 weeks prior to the COVID-19 vaccine included varicella zoster vaccine rge (cho) (SHINGRIX) on 05Mar2021 in the left arm. Concomitant medications included vitamin d nos (VITAMIN D) and unspecified low dose statins; both for unspecified indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies to medications, food or other products. On an unknown date in 2021, the patient experienced severe vertigo, nausea and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event vertigo, nausea and vomiting was recovering at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt started feeling bad the day after his 2nd dose appointment - extreme fatigue and vertigo lasting over 2 weeks. He has been unable to work.
Pt was w/father who reported that pt felt dizzy & anxious. Pt reported improvement after laying down & drinking juice/water. BP 144/90; HR 72; RR 18. Pt was stable & released from vaccination site.
Patient was given Moderna vaccine and shortly after found out this lot (026C21A) is expired as of 10/24/21. Contacted Modera and they confirmed that the lot did expire. Patient did not experience any side effects at the time of this report. Awaiting on guidance from Moderna to see if dose needs to be repeated.
Chills, bodyaches, tiredness  Symptoms started at 10 pm after receiving the shot at 1:30pm Took 2 tylenol at 10 am the day after the injection and syptoms slowly began to subside felt much better by 3PM
1. Pt reports that she had tingling, itching and pins and needles feeling in the left upper arm and radiating down to her hand after receiving the Moderna COVID-19 vaccine on 2/18/2021.  She reports this started about a week after receiving the injection.  She was seen by her doctor on 5/14/2021 for the tingling and itching in her arm and was given Prednisone 10mg tabs (50mg 10 day taper 50,5040,40,30,30...).  On 11/19/2021, she was referred to the clinic for left arm numbness but there are no associate visit notes for that date.  On 12/3/2021 she saw her PCP again for left arm tingling and numbness.  She reported taking a new vitamin Pure encapsulations RevitalAgeNerve Dietary Supplement that was improving the symptoms but not resolving.  She was scheduled for an EMG and given an Rx for Relafen, an NSAID.  She was seen by the pain specialist, doctor on 1/3/2022 and was diagnosed with radiculopathy, cervical region, lesion of radial nerve, left upper limb and carpal tunnel syndrome, left upper limb.  She was referred to neurology/neurosurgery but has not followed up.  She reports that about 14 months after the vaccination the tingling sensation resolved. 2. Pt reports scar at site of injection from 2/18/2021 that has opened, drained and scabbed over 2 times since January 2023.  She reports that the site healed but then randomly opened back up.  She currently has small round scab on upper left extremity where she reports injection was given 2/2021.
Patient complained of chest tightness and pain 6/10. Patients blood pressure and O2 saturation was WNL.  EKG was performed and checked by dr.
Increase urination, sob, dizziness, Ha, fatigue, heart palpitations.
Patient received an MMR vaccine on 12/06/19. Patient developed rash and fever. The nasopharyngeal swab came back positive for measles vaccine strain RNA by real time PCR. By the time the result came back, the child was almost back to normal. No harm to the child.
Red around the vaccination site; This case was reported by a consumer and described the occurrence of injection site erythema in a 69-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st October 2019, the patient received the 2nd dose of Shingrix. In October 2019, less than a week after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional case details were reported as follows: The patient received the vaccine 2 days before the reporting date and the site around the injection was getting red.
Diarrhea. Chills. Arm pain  arm red 2" circle are place of shot. Stomach pain. General ill feeling. Weakness light headed. Tired.
Medical assistant calling to report administered vaccine temperature excursion on multiple patients. Per caller vaccines went out of range yesterday and it was not discovered until this morning when checking the data logger. Multiple AE's filed. See; This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 13-JUN-2022, the patient was vaccinated with improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) 1 injection lot # 1879860 had been verified to be valid, expiration date: 13-OCT-2023, (dose, strength, route of administration and anatomical location were not provided) administered for prophylaxis.   Administered dose of vaccine experienced the temperature excursion. It was reported that the vaccine went out of range on 13-JUN-2022 (reported as "yesterday") (Product storage error) and it was not discovered until the morning on 14-JUN-2022 when checking the data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2206USA004511: US-009507513-2206USA004154: US-009507513-2206USA004187: US-009507513-2206USA004506: US-009507513-2206USA004557:
This is a spontaneous report from a Pfizer-sponsored program, by a contactable other HCP. A 72-year-old male patient received at the age of 71 years PREVNAR 13 (lot number R75238, expiration date 01May2017), intramuscular at 0.5 ml single in left deltoid on 02Aug2017 for immunisation. Medical history included cough. There were no concomitant medications. The patient previously took TESSALON for cough. The patient experienced pneumonia (medically significant) on an unspecified date with outcome of recovering. The patient underwent lab tests and procedures which included on 28Jan2019 chest X-ray, result: pneumonia. The patient received also PREVNAR 13 (lot number: X47910, Expiry Date 01Sep2020) on 26Feb2019 at 0.5 ml single intramuscular injection in right deltoid and he is 72 years. Sender's Comments: Based on the information currently available, the known adverse event profile of the suspect product PREVNAR 13 and the pathophysiology of the event pneumonia, the Company cannot completely exclude that the suspect vaccine contributed to the development of the reported event.
pt recvd flu shot 6OCT92 on 17OCT92 pt had c/o sinus drainage, sore throat, chest congestion, & cough; pt tx'd w/ATB by MD;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 05Oct2023 at 13:00 as dose 1, single (Batch/Lot number: unknown) at the age of 34 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "depression" (unspecified if ongoing). Patient had no known allergies. Concomitant medication(s) included: SERTRALINE, start date: 01Jan2010, stop date: 30Oct2023. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Oct2023) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 with paxlovid from 21Oct2023 to 25Oct2023.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300352131 Same reporter/patient, different drug, different event.;
Soreness at inj. site. Skin inflammation / burning migrated down inner arm approx. 1 in., elbow tenderness x12 h. Inflammation / skin sensitivity x1 week. Low-grade fever x72 hr.
Miscalculated the days between the patient's first and second dose of Pfizer vaccine. The patient received his second COVID vaccine 15 days after his first, instead of 17 days.
About six weeks after my first dose I started having palsies and twitching including spasms of the right eye and lid.  It comes and goes.
Patient called the pharmacy and stated that her arm hurt so severely that she could not move it, she had pain radiating to her jaw and neck, and that any touch caused severe pain to the right arm. Symptoms began about 12-18 hours after vaccination.
experienced a considerable adrenalin spike that was very intense and felt angry; felt tight in chest and airway; This spontaneous case was reported by a consumer and describes the occurrence of ANGER in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Respiratory disorder. Concomitant products included ALBUTEROL for Asthma, MEDROL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANGER. At the time of the report, ANGER (experienced a considerable adrenalin spike that was very intense and felt angry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient mentioned that Within an hour of receiving the first dose of the Moderna vaccine she felt tight in chest and airway, administered 2 puff of albuterol, and then did 2 more puffs, which helped. The same thing happened again 6-8 hours later. She again administered 2 puffs of albuterol and then did 2 more puffs, which helped her.
My jaw started hurting, it hurt to speak, my teeth and gums hurt. My throat filled up and my tongue swelled up which went away by morning. But my hands swelled up to the point that I can't use them and they are very painful. My jaw and teeth and gum pain are still present. I took benadryl as directed by the facility that gave me the vaccine.
She had a hoarse voice and barking cough. She felt warm to the touch, but she didn't have a fever. We took her to the pediatrician's office where she was diagnosed with croup cough and prescribed an oral steroid medication Dexamethasone sodium phosphate 0.7mL for recovery. Her pediatrician tested her COVID-19 which came back negative; her pediatrician couldn't confirm whether receiving two same-day vaccinations affected her immune system and caused the croup cough. As of now, she's doing well and recovering, and recently just went back to daycare.
16 year old pt given Moderna vaccine. Pt is pregnant and due 11/08/2021. Pt did not report any adverse reactions for vaccine given.
Swelling size of baseball on deltoid, redness, itching, tender to the touch.
Information has been received from a licensed practical nurse concerning a 4 year old white male with no known drug allergies who on 08/21/2001 was vaccinated with two doses of MMR II instead of one dose, and one dose of Prevnar. Concomitant vaccination the same day included diphtheria/tetanus toxoid and poliovirus vaccine. There was no additional concomitant medication. There was no illness at the time of vaccinaiton. The child's mother believes he may have been given two doses by mistake. It was reported on 8/23/2001 that the pt has had a fever of 103 F with vomiting for the last two days. The pt sought unspecified medical attention. On 09/04/2001, follow-up info reported that the nurse at the health dept where the child was vaccinated stated that "she wasn't sure if the child received two doses of MMR II or one dose of Prevnar followed by a MMR II vaccine. The nurse also reported that the error was a result of a "miscommunication" and was not due to the product itself. It was reported that the pt's mother was concerned that he might have received 2 MMR's." Additional ifno has been requested.
vax was not given properly and did not go into muscular region, pt  was told to have another round of shots and cannot get so reporting to vaers as per doctor.
This spontaneous report as received from a nurse practitioner refers to a 12 year old female patient. Concurrent condition included penicillin allergy. No concomitant medication were taken. On 29-JUL-2013 the patient was vaccinated with GARDASIL lot # H021861, 1 DF, intramuscularly. Dose number and frequency were not provided. On 30-JUL-2013, the patient woke up and experienced abdominal pain. No treatment was given. The outcome of abdominal pain was reported as not recovered/not resolved. The reporter causality was unknown. Additional information has been requested.